Input-specific modulation of neurotransmitter release in the lateral horn of the spinal cord via adenosine receptors

被引:27
作者
Brooke, RE [1 ]
Deuchars, J [1 ]
Deuchars, SA [1 ]
机构
[1] Univ Leeds, Sch Biomed Sci, Leeds LS2 9NQ, W Yorkshire, England
基金
英国惠康基金;
关键词
adenosine; autonomic; immunoreactivity; patch clamp; spinal; sympathetic;
D O I
10.1523/JNEUROSCI.4591-03.2004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Activation of adenosine A2(A) receptors (A2(A)Rs) in the CNS produces a variety of neuromodulatory actions dependent on the region and preparation examined. In autonomic regions of the spinal cord, A1Ractivation decreases excitatory synaptic transmission, but the effects of A2(A)R stimulation are unknown. We sought to determine the location and function of the A2(A)Rs in the thoracic spinal cord, focusing on the intermediolateral cell column (IML). A2(A)R immunoreactivity was observed throughout the gray matter, with particularly dense immunostaining in regions containing sympathetic preganglionic neurons (SPNs), namely, the IML and intercalated nucleus. Electron microscopy revealed A2(A)R immunoreactivity within presynaptic terminals and in postsynaptic structures in the IML. To study the functional relevance of these A2(A)Rs, visualized whole-cell patch-clamp recordings were made from electrophysiologically identified SPNs and interneurons within the IML. The A2(A)R agonist c2-[p-(carboxyethyl) phenethylamino]-5'-N-ethylcarboxyamidoadenosine (CGS 21680) had no significant effect on EPSPs but increased the amplitude of IPSPs elicited by stimulation of the lateral funiculus. These effects were attributable to activation of presynaptic A2(A)Rs because CGS 21680 application altered the paired pulse ratio. Furthermore, neurons in the IML that have IPSPs increased via A(2)AR-activation also receive excitatory inputs that are inhibited by A1R activation. These data show that activating A2(A)Rs increase inhibitory but not excitatory transmission onto neurons in the IML. Simultaneous activation of A1Rs and A2(A)Rs therefore could facilitate inhibition of the postsynaptic neuron, leading to an overall reduction of sympathetic nervous activity.
引用
收藏
页码:127 / 137
页数:11
相关论文
共 59 条
[1]   Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice [J].
Ådén, U ;
Halldner, L ;
Lagercrantz, H ;
Dalmau, I ;
Ledent, C ;
Fredholm, BB .
STROKE, 2003, 34 (03) :739-744
[2]   FLUORO-GOLD INJECTED EITHER SUBCUTANEOUSLY OR INTRAVASCULARLY RESULTS IN EXTENSIVE RETROGRADE LABELING OF CNS NEURONS HAVING AXONS TERMINATING OUTSIDE THE BLOOD-BRAIN-BARRIER [J].
AMBALAVANAR, R ;
MORRIS, R .
BRAIN RESEARCH, 1989, 505 (01) :171-175
[3]   INTRAPERITONEAL INJECTIONS OF FLUOROGOLD RELIABLY LABELS ALL SYMPATHETIC PREGANGLIONIC NEURONS IN THE RAT [J].
ANDERSON, CR ;
EDWARDS, SL .
JOURNAL OF NEUROSCIENCE METHODS, 1994, 53 (02) :137-141
[4]   ADENOSINE A2A-RECEPTORS IN THE NUCLEUS-ACCUMBENS MEDIATE LOCOMOTOR DEPRESSION [J].
BARRACO, RA ;
MARTENS, KA ;
PARIZON, M ;
NORMILE, HJ .
BRAIN RESEARCH BULLETIN, 1993, 31 (3-4) :397-404
[5]   Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics [J].
Blum, D ;
Hourez, R ;
Galas, MC ;
Popoli, P ;
Schiffmann, SN .
LANCET NEUROLOGY, 2003, 2 (06) :366-374
[6]   Spinal cord interneurones labelled transneuronally from the adrenal gland by a GFP-herpes virus construct contain the potassium channel subunit Kv3.1b [J].
Brooke, RE ;
Pyner, S ;
McLeish, P ;
Buchan, S ;
Deuchars, J ;
Deuchars, SA .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2002, 98 (1-2) :45-50
[7]   Ongoing and stimulus-evoked activity of sympathetically correlated neurons in the intermediate zone and dorsal horn of acutely spinalized rats [J].
Chau, D ;
Johns, DG ;
Schramm, LP .
JOURNAL OF NEUROPHYSIOLOGY, 2000, 83 (05) :2699-2707
[8]  
CHOCA JI, 1987, J PHARMACOL EXP THER, V242, P905
[9]  
CHOCA JI, 1988, J PHARMACOL EXP THER, V247, P757
[10]   TONIC ADENOSINE A(2A) RECEPTOR ACTIVATION MODULATES NICOTINIC AUTORECEPTOR FUNCTION AT THE RAT NEUROMUSCULAR-JUNCTION [J].
CORREIADESA, P ;
RIBEIRO, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 271 (2-3) :349-355